Combined use of painkillers, antidepressants may increase bleeding risk
the ONA take:
According to a study published this week in The BMJ, researchers have found that combined use of antidepressants and NSAID painkillers is associated with an increased risk of bleeding.
For the study, researchers analyzed data from more than 4 million people who were prescribed antidepressants between 2009 and 2013 included in the Korean nationwide health insurance database. Researchers compared the time to first admission with intracranial hemorrhage within 30 days of a new prescription among patients with antidepressants and NSAIDs compared with those with only antidepressants.
Results showed a substantially increased bleeding risk among those who took both prescription medications. Moreover, there was no statistically significant difference in risk of bleeding with age or different classes of antidepressant medications. Male gender was also found to be associated with a higher risk of bleeding among those who were prescribed the combination.
The authors note that their results may have been impacted by other factors and caution is advised when interpreting the results; however, health care professionals should use caution in patients who are prescribed both types of medications.
Researchers have found that combined use of antidepressants and NSAID painkillers is associated with an increased risk of bleeding.
- Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma
- New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer
- Superior Tolerability, Efficacy With Alectinib in Treatment-Naïve ALK-poistive NSCLC
- Adding Pertuzumab to Adjuvant Therapy Is Beneficial for Some Women with Early Breast Cancer
- Clinical Trials May Benefit Oncology Patients
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Breast Cancer Diagnosis and Nurse Navigation Survey
- Prostate-specific PET and CT Imaging Improves Detection of Disease and Patient Care
- Lenvatinib Improves OS, PFS in Radioiodine-Refractory Differentiated Thyroid Cancer in All Older Patients
- Breast Cancer Overdiagnosis Also a Result of Screening Mammography Programs
- Use of Aspirin, NSAIDs Correlates with Improved Overall Survival in Colorectal Cancer
- Cancer Risk Not Increased by Childhood Exposure to Diagnostic Radiation
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|